Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis?
about
HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-betaCryptolepine derivative-6h inhibits liver fibrosis in TGF-β1-induced HSC-T6 cells by targeting the Shh pathway.Overexpression of Regulatory T Cells Type 1 (Tr1) Specific Markers in a Patient with HCV-Induced Hepatocellular Carcinoma.Active immunization against transforming growth factor beta1 prevents hepatic fibrosis in a rat model of liver disease.Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.Hepatoprotective effects of early pentoxifylline administration on hepatic injury induced by concanavalin A in rat.
P2860
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@en
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@nl
type
label
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@en
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@nl
prefLabel
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@en
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@nl
P2093
P2860
P1476
Can serum TGF-beta 1 be used t ...... HCV-related chronic hepatitis?
@en
P2093
P2860
P304
P356
10.1177/039463200802100426
P577
2008-10-01T00:00:00Z